Inflammatory Arthritis Clinical Trial
— AHRTOfficial title:
Allied Health in Rheumatology Triage Project
Verified date | June 2015 |
Source | Sunnybrook Health Sciences Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Institutional Review Board |
Study type | Interventional |
There is accumulating evidence that early treatment leads to better outcomes for patients with inflammatory arthritis (IA). Triage, which is the process of identifying the urgency of a patient's disease state efficiently and correctly, may facilitate early referral to a rheumatologist. Several studies have suggested that placing allied health professionals (occupational therapists, physical therapists, nurses, etc.) in a triage roll may reduce wait time for patients with suspected IA. The goal of this investigation will be to demonstrate the system-level impact of an Arthritis Society extended role occupational therapist (OT) or physical therapist (PT) working in a triage role in improving access to rheumatologists for people with IA. In this study two groups will be observed: intervention and "usual care" as determined by historical chart review. Wait times will be compared between both groups.
Status | Completed |
Enrollment | 295 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - New referrals from a GP - Adults with possible IA (determined by rheumatologist through paper triage) Exclusion Criteria: - Currently on a disease-modifying antirheumatic drug (DMARD) - Previously seen by a rheumatologist. - FM, non-IA OA; soft tissue rheumatism; mechanical LBP |
Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sunnybrook Health Sciences Centre | Ontario Best Practices Research Initiative, Ontario Rheumatology Association, The Arthritis Society, Canada |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to first visit with the rheumatologist (wait time) | 3 months | No | |
Secondary | Time to diagnosis | 3 months | No | |
Secondary | Time to treatment (disease-modifying antirheumatic drug) | 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04249817 -
Keeping Stable Inflammatory Arthritis Patients in Their Communities With the Advanced Clinician Practitioner in Arthritis Care
|
N/A | |
Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
Completed |
NCT01303874 -
Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
|
Phase 4 | |
Active, not recruiting |
NCT03343171 -
Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
|
||
Recruiting |
NCT04426747 -
Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis
|
||
Active, not recruiting |
NCT04956380 -
Self-assessment Triage in Inflammatory Arthritis
|
N/A | |
Active, not recruiting |
NCT02538757 -
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
|
Phase 2 | |
Completed |
NCT01874067 -
C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
|
||
Completed |
NCT03140995 -
Sleep and Exercise in Rheumatoid Arthritis
|
N/A | |
Withdrawn |
NCT02027298 -
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
|
Phase 2 | |
Recruiting |
NCT00512239 -
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
|
||
Terminated |
NCT03937856 -
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT02436785 -
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
|
N/A | |
Completed |
NCT02538341 -
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
|
Phase 2 | |
Completed |
NCT03672916 -
Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
|
||
Completed |
NCT04806867 -
Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
|
||
Active, not recruiting |
NCT01307384 -
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
|
||
Terminated |
NCT03672370 -
PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty
|
||
Not yet recruiting |
NCT05216757 -
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
|
Phase 2/Phase 3 | |
Withdrawn |
NCT02092246 -
Ultrasound Guided vs Unguided Intra-articular Knee Injections
|
Phase 3 |